Current position

Goldman Sachs Group Inc.’s Stryker Corporation (SYK) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Goldman Sachs Group Inc.Verified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ3 2016Earliest verified positive filing snapshot
Latest statusCurrent positionBased on the latest supported relationship state
Peak shares2.78MHighest verified quarter-end share count
Quarters reported25Verified quarters with shares above zero
What happened?

Goldman Sachs Group Inc. first reported Stryker Corporation in Q3 2016. The reported position was increased and reduced across later filings. Goldman Sachs Group Inc. currently reports 2.78M shares. The latest verified filing showed: Bought 4.3% more.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2026
Bought 4.3% more+113.95K shares · 2.78M shares reported after the change
Filing context

Quarter-end price $314.84

Q1 2026
Bought 24.2% more+519.95K shares · 2.67M shares reported after the change
Filing context

Quarter-end price $328.59

Q4 2025
Sold 12.1% of the position−295.37K shares · 2.15M shares remained
Filing context

Quarter-end price $351.47

Q3 2025
Bought 20.8% more+420.78K shares · 2.45M shares reported after the change
Filing context

Quarter-end price $369.67

Q2 2025
Sold 8.7% of the position−192.92K shares · 2.02M shares remained
Filing context

Quarter-end price $395.63

Q1 2025
Bought 7.5% more+155.06K shares · 2.22M shares reported after the change
Filing context

Quarter-end price $372.25

Portfolio importance

How important is Stryker Corporation in Goldman Sachs Group Inc.’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Current portfolio weight0.1%Q2 2026
Current rank#238of 6524 reported positions
Peak portfolio weight0.1%Q4 2023
Best historical rank#135Q1 2025
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest filing quarter-end price$314.84Q2 2026

Derived from validated reported value and shares where supported.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

Coverage is bounded to the institution’s top reported positions and material events rather than every security in each Form 13F. Source filings may contain additional securities, and 13F filings do not reveal exact trade dates or execution prices.